Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis

J Virol. 2002 Nov;76(21):10921-8. doi: 10.1128/jvi.76.21.10921-10928.2002.

Abstract

The isolation of a capsid intertypic poliovirus recombinant from a child with vaccine-associated paralytic poliomyelitis is described. Virus 31043 had a Sabin-derived type 3-type 2-type 1 recombinant genome with a 5'-end crossover point within the capsid coding region. The result was a poliovirus chimera containing the entire coding sequence for antigenic site 3a derived from the Sabin type 2 strain. The recombinant virus showed altered antigenic properties but did not acquire type 2 antigenic characteristics. The significance of the presence in nature of such poliovirus chimeras and the consequences for the current efforts to detect potentially dangerous vaccine-derived poliovirus strains are discussed in the context of the global polio eradication initiative.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antigens, Viral / genetics*
  • Antigens, Viral / immunology
  • Capsid / immunology
  • Child, Preschool
  • Crossing Over, Genetic*
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Neutralization Tests
  • Paralysis / immunology
  • Paralysis / virology*
  • Poliomyelitis / immunology
  • Poliomyelitis / virology*
  • Poliovirus / genetics*
  • Poliovirus / immunology
  • Poliovirus Vaccine, Oral / adverse effects
  • Poliovirus Vaccine, Oral / genetics*
  • Poliovirus Vaccine, Oral / immunology
  • Sequence Analysis, DNA
  • Temperature
  • Tumor Cells, Cultured
  • Virulence

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Poliovirus Vaccine, Oral